Published in Neuropsychology on May 01, 2006
Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev (2009) 2.86
Attention deficit in depressed suicide attempters. Psychiatry Res (2008) 1.30
fMRI brain activation during a delay discounting task in HIV-positive adults with and without cocaine dependence. Psychiatry Res (2011) 1.07
A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale. PLoS One (2013) 0.97
Cognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action. Neuropsychol Rev (2013) 0.95
Working memory deficits affect risky decision-making in methamphetamine users with attention-deficit/hyperactivity disorder. J Psychiatr Res (2012) 0.95
Callosal degradation in HIV-1 infection predicts hierarchical perception: a DTI study. Neuropsychologia (2009) 0.94
Sex and HIV serostatus differences in decision making under risk among substance-dependent individuals. J Clin Exp Neuropsychol (2016) 0.88
Emerging issues in the neuropsychology of HIV infection. Curr HIV/AIDS Rep (2008) 0.88
HIV+ men and women show different performance patterns on procedural learning tasks. J Clin Exp Neuropsychol (2010) 0.87
Decision making among HIV+ drug using men who have sex with men: a preliminary report from the Chicago Multicenter AIDS Cohort Study. J Clin Exp Neuropsychol (2013) 0.85
Computational modeling reveals distinct effects of HIV and history of drug use on decision-making processes in women. PLoS One (2013) 0.85
Select neurocognitive impairment in HIV-infected women: associations with HIV viral load, hepatitis C virus, and depression, but not leukocyte telomere length. PLoS One (2014) 0.83
Risky decision-making in HIV-associated neurocognitive disorders (HAND). Clin Neuropsychol (2012) 0.83
The role of HIV infection, cognition, and depression in risky decision-making. J Neuropsychiatry Clin Neurosci (2012) 0.83
Antiretroviral adherence and the nature of HIV-associated verbal memory impairment. J Neuropsychiatry Clin Neurosci (2011) 0.82
Influence of procedural learning on Iowa Gambling Task performance among HIV+ individuals with history of substance dependence. Arch Clin Neuropsychol (2009) 0.81
Altered functional response to risky choice in HIV infection. PLoS One (2014) 0.81
Effects of NMDA receptor antagonists on probability discounting depend on the order of probability presentation. Pharmacol Biochem Behav (2016) 0.76
A deconstruction of gambling task performance among HIV+ individuals: the differential contributions of problem solving and risk taking. J Clin Exp Neuropsychol (2013) 0.76
The roles of social stress and decision-making in non-suicidal self-injury. Psychiatry Res (2015) 0.76
Health-Related Decision-Making in HIV Disease. J Clin Psychol Med Settings (2016) 0.76
Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1. J Neurovirol (2016) 0.75
Compensatory activation in fronto-parietal cortices among HIV-infected persons during a monetary decision-making task. Hum Brain Mapp (2016) 0.75
Affective differences in Iowa Gambling Task performance associated with sexual risk taking and substance use among HIV-positive and HIV-negative men who have sex with men. J Clin Exp Neuropsychol (2016) 0.75
Chronic Tobacco-Smoking on Psychopathological Symptoms, Impulsivity and Cognitive Deficits in HIV-Infected Individuals. J Neuroimmune Pharmacol (2017) 0.75
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep (1992) 22.29
Insensitivity to future consequences following damage to human prefrontal cortex. Cognition (1994) 14.92
The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health (1996) 9.20
Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills (1977) 6.58
Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. Brain (2000) 6.01
Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making. J Neurosci (1999) 5.78
Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia (2001) 4.71
Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia (2002) 3.42
Dissociation Of working memory from decision making within the human prefrontal cortex. J Neurosci (1998) 3.28
HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 3.17
Decision-making processes following damage to the prefrontal cortex. Brain (2002) 3.07
Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia (2000) 2.82
Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward? Neuropsychologia (2002) 2.64
A contribution of cognitive decision models to clinical assessment: decomposing performance on the Bechara gambling task. Psychol Assess (2002) 2.32
Cognitive impulsivity and HIV serostatus in substance dependent males. J Int Neuropsychol Soc (2004) 1.28
Risky decision making in Huntington's disease. J Int Neuropsychol Soc (2001) 1.08
HIV encephalitis simulating Huntington's disease. Mov Disord (2005) 0.89
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol (2004) 5.18
Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS (2004) 5.04
Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav (2007) 2.98
Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol (2007) 2.62
Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat (2006) 2.17
Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst (2013) 1.86
Aging, neurocognition, and medication adherence in HIV infection. Am J Geriatr Psychiatry (2009) 1.64
Functional consequences of HIV-associated neuropsychological impairment. Neuropsychol Rev (2009) 1.54
Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology (2010) 1.50
Medication and finance management among HIV-infected adults: the impact of age and cognition. J Clin Exp Neuropsychol (2010) 1.46
Adherence to antiretroviral medications in HIV: differences in data collected via self-report and electronic monitoring. Health Psychol (2006) 1.41
Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS Behav (2011) 1.35
Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS Behav (2005) 1.31
Neurocognition in individuals co-infected with HIV and hepatitis C. J Addict Dis (2008) 1.30
The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS One (2012) 1.27
Depression, cognition, and self-appraisal of functional abilities in HIV: an examination of subjective appraisal versus objective performance. Clin Neuropsychol (2011) 1.21
The effect of recent stimulant use on sustained attention in HIV-infected adults. J Clin Exp Neuropsychol (2006) 1.17
Differential predictors of medication adherence in HIV: findings from a sample of African American and Caucasian HIV-positive drug-using adults. AIDS Patient Care STDS (2012) 1.16
Editorial neuroAIDS review. AIDS (2011) 1.10
Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers. AIDS (2012) 1.09
Reaction time performance in adults with HIV/AIDS. J Clin Exp Neuropsychol (2002) 1.09
Components of depression in HIV-1 infection: their differential relationship to neurocognitive performance. J Clin Exp Neuropsychol (2006) 1.08
Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Clin Infect Dis (2005) 1.07
Verbal and spatial working memory performance among HIV-infected adults. J Int Neuropsychol Soc (2002) 1.05
Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age. Clin Neuropsychol (2010) 1.02
Multi-dimensional MR spectroscopy: towards a better understanding of hepatic encephalopathy. Metab Brain Dis (2011) 1.00
Functional disability in medication management and driving among individuals with HIV: a 1-year follow-up study. J Clin Exp Neuropsychol (2012) 0.95
Reaction time variability in HIV-positive individuals. Arch Clin Neuropsychol (2010) 0.94
Elements of attention in HIV-infected adults: evaluation of an existing model. J Clin Exp Neuropsychol (2007) 0.93
CCL3 genotype and current depression increase risk of HIV-associated dementia. Neurobehav HIV Med (2009) 0.93
Relationship between psychiatric status and frontal-subcortical systems in HIV-infected individuals. J Int Neuropsychol Soc (2007) 0.93
Basal ganglia structures differentially contribute to verbal fluency: evidence from Human Immunodeficiency Virus (HIV)-infected adults. Neuropsychologia (2011) 0.92
Emerging issues in the neuropsychology of HIV infection. Curr HIV/AIDS Rep (2008) 0.88
Host genetic factors predisposing to HIV-associated neurocognitive disorder. Curr HIV/AIDS Rep (2014) 0.88
The impact of neurobehavioral features on medication adherence in HIV: evidence from longitudinal models. AIDS Care (2013) 0.88
The Item-Specific Deficit Approach to evaluating verbal memory dysfunction: rationale, psychometrics, and application. J Clin Exp Neuropsychol (2009) 0.87
Perceptual span deficits in adults with HIV. J Int Neuropsychol Soc (2004) 0.87
An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adults. J Clin Exp Neuropsychol (2008) 0.87
Hormone replacement therapy and risk for neurodegenerative diseases. Int J Alzheimers Dis (2012) 0.86
Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease. BMC Med Genomics (2013) 0.86
2D MR Spectroscopy Combined with Prior-Knowledge Fitting Is Sensitive to HCV-Associated Cerebral Metabolic Abnormalities. Int J Hepatol (2012) 0.86
Cognitive reserve as a protective factor in older HIV-positive patients at risk for cognitive decline. Appl Neuropsychol Adult (2012) 0.85
Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints. Brain Imaging Behav (2013) 0.85
Reaction time slowing in adults with HIV: results of a meta-analysis using brinley plots. Brain Cogn (2002) 0.83
The role of HIV infection, cognition, and depression in risky decision-making. J Neuropsychiatry Clin Neurosci (2012) 0.83
Molecular epigenetics, chromatin, and NeuroAIDS/HIV: translational implications. Bioinformation (2008) 0.82
The generalizability of neurocognitive test/retest data derived from a nonclinical sample for detecting change among two HIV+ cohorts. J Clin Exp Neuropsychol (2007) 0.82
Antiretroviral adherence and the nature of HIV-associated verbal memory impairment. J Neuropsychiatry Clin Neurosci (2011) 0.82
Subcortical hyperintensities in Alzheimer's disease: associated clinical and metabolic findings. J Neuropsychiatry Clin Neurosci (2002) 0.82
Mixed membership trajectory models of cognitive impairment in the multicenter AIDS cohort study. AIDS (2015) 0.81
Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine. Neurology (2005) 0.81
Sensation seeking and visual selective attention in adults with HIV/AIDS. AIDS Behav (2007) 0.81
Effects of stereotype threat, perceived discrimination, and examiner race on neuropsychological performance: simple as black and white? J Int Neuropsychol Soc (2013) 0.81
Neuropsychological Dysfunction among HIV Infected Drug Abusers. Am J Infect Dis (2006) 0.79
Correlates of functional status among OEF/OIF veterans with a history of traumatic brain injury. Mil Med (2012) 0.78
Two-dimensional MR spectroscopy of minimal hepatic encephalopathy and neuropsychological correlates in vivo. J Magn Reson Imaging (2010) 0.78
Factors related to HIV-associated neurocognitive impairment differ with age. J Neurovirol (2014) 0.78
The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals. J Clin Exp Neuropsychol (2013) 0.78
The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients. AIDS (2015) 0.78
A deconstruction of gambling task performance among HIV+ individuals: the differential contributions of problem solving and risk taking. J Clin Exp Neuropsychol (2013) 0.76
Stability of human immunodeficiency virus type 1 RNA in cerebrospinal fluid determined with the AMPLICOR HIV-1 MONITOR test, version 1.5 (ultrasensitive). J Clin Microbiol (2002) 0.75
Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection. AIDS (2017) 0.75
Estrogen, tamoxifen, and the brain. J Natl Cancer Inst (2002) 0.75
Neuropsychological exploration of alleged mold neurotoxicity. Arch Clin Neuropsychol (2007) 0.75
HIV-1 envelope accessible surface and polarity: clade, blood, and brain. Bioinformation (2011) 0.75
Exploring the impact of the hormonal milieu on cognitive functioning. J Clin Oncol (2009) 0.75
Longitudinal Intra-Individual Variability in Neuropsychological Performance Relates to White Matter Changes in HIV. Neuropsychology (2017) 0.75